NEWS

2011 International Symposium on Malignant Mesothelioma

January 21, 2011

SAVE THE DATE

June 23-25, 2011 in Washington, DC. For more information visit curemeso.org/symposium. Stay tuned…

In Other News

CAR-T Cell Therapy as Treatment for Mesothelioma Patients

CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white

FDA Approves KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Patients with Unresectable or Metastatic Malignant Pleural Mesothelioma

For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with

Bret A Rosenthal Patient Assistance Fund: A New Service to Help Younger Patients with Their Unique Needs

Mesothelioma has often been classified as a cancer that only affects older people, as the average age of diagnosis for pleural is 72 and peritoneal

1717 K Street NW, Suite 900

(877) 363-6376

Find a specialist experienced in the treatment of mesothelioma

GENERAL INFORMATION

TYPES OF MESOTHELIOMA

TREATMENT

SUPPORT

We can help guide you through the selection of medical specialists and treatments including clinical trials.

Explore topics about mesothelioma

WATCH, LISTEN, READ, LEARN

We can help guide you through the selection of medical specialists and treatments including clinical trials.

PARTICIPATE

Explore topics about mesothelioma

2011 International Symposium on Malignant Mesothelioma

In Other News

Share:

Patients and Families

About

Researchers

Read